Keynote Speakers

Keynote Speakers

Meet ASPET 2024 Annual Meeting Keynote Speaker

Marie A. Bernard, M.D.

Chief Officer for Scientific Workforce Diversity (COSWD)

Diverse Perspectives in Science: Why and How?

Marie A. Bernard, M.D., is the National Institutes of Health (NIH)* Chief Officer for Scientific Workforce Diversity (COSWD). As the COSWD, she leads NIH thought regarding the science of scientific workforce diversity, assuring that the full range of talent is accessed to promote scientific creativity and innovation. Dr. Bernard co-led the development and is co-leading the implementation of the Fiscal Years 2023 – 2027 NIH-wide Strategic Plan for Diversity, Equity, Inclusion, and Accessibility (DEIA). She also cochairs the NIH Advisory Committee to the Director Working Group on Diversity, the NIH Steering Committee Working Group on DEIA, and the NIH UNITE initiative to identify and address any structural racism that may exist within NIH and throughout the biomedical and behavioral workforce. Prior to being selected as the COSWD, Dr. Bernard served as the Deputy Director of the National Institute on Aging (NIA), following a productive research and leadership career as an academic geriatrician.

*Disclaimer: No endorsement of ASPET, their programs or services, by NIH is intended.

Shehnaaz Suliman, M.D., M.Phil. MBA

CEO ReCode Therapeutics

Dr. Shehnaaz Suliman is CEO of ReCode Therapeutics – a leading genetic medicines company focused on powering the next wave of genetic medicines through tissue-specific lipid nanoparticle delivery. Dr. Suliman is a physician, drug-developer, company builder and has played a leading role over 25 years in transforming high growth companies through advancing clinical pipelines and executing partnerships and acquisitions at Alector, Theravance, Genentech, Roche and Gilead. Dr. Suliman has been honored by Forbes, Fierce Biotech, Silicon Valley Business Journal and San Francisco Business Times as a nationally acclaimed leader female business leader and advocate for healthcare equity and access. She received her M.D. at the University of Cape Town Medical School, South Africa, and holds an MBA, with distinction, and M.Phil. degrees from Oxford University, where she was a Rhodes Scholar. Dr. Suliman serves on the Ultragenyx Pharmaceutical and 10x Genomic Boards. Dr. Suliman is forging paths for underrepresented individuals with the Board Room Ready program and is a mentor to dozens of rising stars.